
The Clinical Trials Toolkit provides practical advice to researchers in designing and conducting publicly funded clinical trials in the UK. Through the use of an interactive routemap, this site provides information on best practice and outlines the current legal and practical requirements for conducting clinical trials.
The Toolkit is primarily focused on Clinical Trials of Investigational Medicinal Products (CTIMPs) and the regulatory environment and requirements associated with these. However researchers and R&D staff working on trials in other areas will also find useful information and guidance of relevance to the wider trials environment.
Please note the Toolkit describes the requirements for Clinical Trials of Investigational Medicinal Products (CTIMPs) brought about by the introduction of the European Commission Directive 2001/20/EC. A proposal to repeal Directive 2001/20/EC and replace it with a European Regulation has been published. As this new Regulation has not been finalised, its content is not widely discussed within this Toolkit at this stage. However, the site will consider the implications of any confirmed change in due course and provide updated information and guidance as agreed.
Latest Clinical Trials Toolkit news
Draft ICH E8 (R1) Guidance Released
The ICH E8(R1) draft Guideline on General Considerations for Clinical Trials has entered the public consultation period.Plans for Clinical Trials Post Brexit
The HRA and MHRA have published plans for clinical trials in the event of a no-deal Brexit.New Best Practice Principles for Public Involvement
The HRA have launched new guidelines on how to involve patients and the public well in research.